Trending Topic

Stastical analysis indication diabetes mellitus .generative ai
5 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Saptarshi Bhattacharya, Sanjay Kalra, Lakshmi Nagendra

Very few trials in the history of medical science have altered the treatment landscape as profoundly as the UK Prospective Diabetes Study (UKPDS). Even 44 years after its inception, the trial and post-study follow-up findings continue to fascinate and enlighten the medical community. The study was conceived at a time when there was uncertainty about […]

2 mins

The International Diabetes Federation World Diabetes Congress 2015

Bernard Zinman
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Published Online: Aug 19th 2015 European Endocrinology, 2015;11(2):66 DOI: http://doi.org/10.17925/EE.2015.11.02.66
Select a Section…
1

Article

Bernard Zinman, Programme Committee Chair of the International Diabetes Federation (IDF) World Diabetes Congress 2015, talks about the scientific programme highlights, the experience of attending the Congress and his involvement in diabetes care and research. Bernard Zinman is Director of the Leadership Sinai Centre for Diabetes and holds the Sam and Judy Pencer Family Chair in Diabetes Research at Mount Sinai Hospital and the University of Toronto, Canada. He is Professor of Medicine at the University of Toronto and Senior Scientist at the Samuel Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, Ontario, Canada.

Q&A with Bernard Zinman, Chair,
International Diabetes Federation World Diabetes Congress 2015 Programme Committee

1. What are going to be the highlights of the
congress scientific programme?

The International Diabetes Federation (IDF) World Diabetes Congress (WDC) 2015 will be held in an outstanding venue in Vancouver, Canada. The programme will comprise symposia, debates, workshops, meet-theexpert and poster discussion sessions, and will present recent advances in six distinct streams including: Basic and Clinical Science, Diabetes in Indigenous Peoples, Education and Integrated Care, Global Challenges in Health, Public Health and Epidemiology and Living with Diabetes.

2. Who should attend the congress and what can
delegates expect from the experience?

Members of broad-based multi-disciplinary diabetes health care teams, individuals active in diabetes organisations, people with diabetes, diabetes-related industries and health ministries of various government sectors will all benefit from the diverse programme.

3. What makes the IDF WDC unique?

The uniqueness of the IDF WDC derives from its international flavour, the diverse background of its participants and the integration of cuttingedge research with education and clinical care. It truly is a unique event for people involved with every component of the diabetes community to meet and exchange ideas.

4. What was your motivation for becoming
involved in diabetes care and research?

My background in biochemistry and passion for research directed me to a career as a clinician scientist in endocrinology with a major focus in diabetes.


5. Diabetes rates in North America are on the
rise, what must we do to combat this?

To effectively address the epidemic of diabetes we need three approaches. First, we need to develop effective strategies to prevent diabetes with a focus on reversing the increasing rates of obesity and physical inactivity particularly as it relates to our children. Second, we need to develop and implement effective diabetes treatment regimens very early on in the course of the disease to prevent the devastating complications of diabetes. And finally, for those with diabetes and complications, we need to screen efficiently for these complications and apply effective treatment before they become disabling and affect the long-term outcomes and quality of life.

2

Article Information

Disclosure

Bernard Zinman has no conflicts of interest to disclose. No funding was received for the publication of this article.
Open Access: This article is published under the Creative Commons Attribution Noncommercial License, which permits any non-commercial use, distribution, adaptation
and reproduction provided the original author(s) and source are given appropriate credit.

Correspondence

Bernard Zinman, Samuel Lunenfeld Research Institute, University of Toronto, Toronto, ON, Canada. E: zinman@lunenfeld.ca

Received

2015-07-17T00:00:00

3

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Close Popup